Graham Capital Management, L.P.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1315421 ROWAYTON, CT

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$327,823

-$220,304 QoQ

Shares Held

42,741

-11.8% QoQ

Ownership

0.064%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#77

of 168 holders

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Graham Capital Management, L.P. holds $14,536,772 across 66 Biotechnology names. FULC ranks #19 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	4,606	$870,764
2	TECH	BIO-TECHNE Corp	9,949	$519,934
3	SRPT	Sarepta Therapeutics, Inc.	22,442	$488,337
4	BHVN	Biohaven Ltd.	55,399	$468,675
5	NUVL	Nuvalent, Inc.	4,112	$421,274
6	ADMA	Adma Biologics, Inc.	45,222	$407,450
7	MNKD	Mannkind Corp	161,189	$394,913
8	ABCL	AbCellera Biologics Inc.	112,831	$393,780

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$327,823	42,741	-11.8%	Shares	Sole	2026-05-15
2025-12-31	$548,127	48,464	+59.0%	Shares	Sole	2026-02-17
2025-09-30	$280,471	30,486	+153.0%	Shares	Sole	2025-11-14
2025-06-30	$82,917	12,052	-92.8%	Shares	Sole	2025-08-14
2025-03-31	$478,779	166,243	+14.7%	Shares	Sole	2025-05-15
2024-12-31	$681,227	144,942	+58.9%	Shares	Sole	2025-02-14
2024-09-30	$325,641	91,216	+670.1%	Shares	Sole	2024-11-14
2023-09-30	$52,591	11,845	-62.9%	Shares	Sole	2023-11-22
2023-06-30	$105,428	31,948	-78.3%	Shares	Sole	2023-08-14
2023-03-31	$418,890	146,979	+588.3%	Shares	Sole	2023-05-15
2022-12-31	$155,449	21,353	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.